{
    "PMC5564609_3": [
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "delayed gastric emptying"
            },
            "measures": "[incidence]",
            "outcomes": "[15]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "delayed gastric emptying"
            },
            "measures": "[incidence]",
            "outcomes": "[32]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "bleeding"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "bleeding"
            },
            "measures": "[incidence]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pancreatic fistula"
            },
            "measures": "[incidence]",
            "outcomes": "[39]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pancreatic fistula"
            },
            "measures": "[incidence]",
            "outcomes": "[36]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pancreatic fistula",
                "grade": "A"
            },
            "measures": "[incidence]",
            "outcomes": "[8]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pancreatic fistula",
                "grade": "A"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pancreatic fistula",
                "grade": "B"
            },
            "measures": "[incidence]",
            "outcomes": "[10]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pancreatic fistula",
                "grade": "B"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pancreatic fistula",
                "grade": "C"
            },
            "measures": "[incidence]",
            "outcomes": "[21]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pancreatic fistula",
                "grade": "C"
            },
            "measures": "[incidence]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "biliary fistula"
            },
            "measures": "[incidence]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "biliary fistula"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "wound infection"
            },
            "measures": "[incidence]",
            "outcomes": "[5]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "wound infection"
            },
            "measures": "[incidence]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pulmonary complication"
            },
            "measures": "[incidence]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pulmonary complication"
            },
            "measures": "[incidence]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "skin orifice infection"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "skin orifice infection"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "abdominal abscess"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "abdominal abscess"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "pancreatitis"
            },
            "measures": "[incidence]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "pancreatitis"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "sepsis"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "sepsis"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "re-laparotomy"
            },
            "measures": "[incidence]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "re-laparotomy"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "mortality"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "mortality"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "group": "ERAS",
                "sample_size": "76",
                "complication": "readmission",
                "time_frame": "in 30 days"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "group": "Conventional",
                "sample_size": "83",
                "complication": "readmission",
                "time_frame": "in 30 days"
            },
            "measures": "[incidence]",
            "outcomes": "[1]"
        }
    ],
    "PMC3798558_1": [
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "n": "185"
            },
            "measures": "[<40, \u226540 but <50, \u226550 but <60, \u226560 but <70, \u226570]",
            "outcomes": "[10 (5.41), 19 (10.27), 60 (32.43), 60 (32.43), 36 (19.46)]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[<40, \u226540 but <50, \u226550 but <60, \u226560 but <70, \u226570]",
            "outcomes": "[75 (5.12), 147 (10.03), 479 (32.70), 484 (33.04), 280 (19.11)]"
        },
        {
            "subject": {
                "characteristic": "age",
                "p-value": "0.999"
            }
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "cases",
                "n": "185"
            },
            "measures": "[male, female]",
            "outcomes": "[127 (68.65), 58 (31.35)]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[male, female]",
            "outcomes": "[1097 (74.88), 368 (25.12)]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "p-value": "0.068"
            }
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "unit": "kg/m2",
                "group": "cases",
                "n": "185"
            },
            "measures": "[<18.5, \u226518.5 but <22.5, \u226522.5 but <25, \u226525 but <27.5, \u226527.5, unknown]",
            "outcomes": "[15 (8.11), 84 (45.11), 47 (25.41), 25 (13.51), 14 (7.57), 0 (0.00)]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "unit": "kg/m2",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[<18.5, \u226518.5 but <22.5, \u226522.5 but <25, \u226525 but <27.5, \u226527.5, unknown]",
            "outcomes": "[61 (4.16), 555 (37.88), 478 (32.63), 245 (16.72), 111 (7.58), 15 (1.02)]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "p-value": "0.021"
            }
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "unit": "kg/m2",
                "group": "cases",
                "n": "185"
            },
            "measures": "[<18.5, \u226518.5 but <22.5, \u226522.5 but <25, \u226525 but <27.5, \u226527.5, unknown]",
            "outcomes": "[14 (7.57), 112 (60.54), 36 (19.46), 11 (5.95), 6 (3.24), 6 (3.24)]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "unit": "kg/m2",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[<18.5, \u226518.5 but <22.5, \u226522.5 but <25, \u226525 but <27.5, \u226527.5, unknown]",
            "outcomes": "[168 (11.47), 950 (64.85), 226 (15.43), 72 (4.91), 14 (0.96), 35 (2.39)]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "p-value": "0.018"
            }
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "n": "185"
            },
            "measures": "[<5, \u22655 but <20, \u226520 but <40, \u226540, unknown]",
            "outcomes": "[69 (37.30), 22 (11.89), 34 (18.38), 60 (32.43), 0 (0.00)]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[<5, \u22655 but <20, \u226520 but <40, \u226540, unknown]",
            "outcomes": "[638 (43.55), 206 (14.06), 308 (21.02), 304 (20.75), 9 (0.61)]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "p-value": "0.005"
            }
        },
        {
            "subject": {
                "characteristic": "drinking",
                "unit": "g ethanol/day",
                "group": "cases",
                "n": "185"
            },
            "measures": "[non, <23, \u226523 but <46, \u226546, unknown]",
            "outcomes": "[56 (30.27), 53 (28.65), 43 (23.24), 31 (16.76), 2 (1.08)]"
        },
        {
            "subject": {
                "characteristic": "drinking",
                "unit": "g ethanol/day",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[non, <23, \u226523 but <46, \u226546, unknown]",
            "outcomes": "[488 (33.31), 425 (29.01), 342 (23.34), 193 (13.17), 17 (1.16)]"
        },
        {
            "subject": {
                "characteristic": "drinking",
                "p-value": "0.568"
            }
        },
        {
            "subject": {
                "characteristic": "history of diabetes mellitus",
                "group": "cases",
                "n": "185"
            },
            "measures": "[yes, no]",
            "outcomes": "[37 (20.00), 148 (80.00)]"
        },
        {
            "subject": {
                "characteristic": "history of diabetes mellitus",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[yes, no]",
            "outcomes": "[126 (8.60), 1339 (91.40)]"
        },
        {
            "subject": {
                "characteristic": "history of diabetes mellitus",
                "p-value": "<0.001"
            }
        },
        {
            "subject": {
                "characteristic": "family history of PC",
                "group": "cases",
                "n": "185"
            },
            "measures": "[yes, no]",
            "outcomes": "[8 (4.32), 177 (95.68)]"
        },
        {
            "subject": {
                "characteristic": "family history of PC",
                "group": "controls",
                "n": "1465"
            },
            "measures": "[yes, no]",
            "outcomes": "[58 (3.96), 1407 (96.04)]"
        },
        {
            "subject": {
                "characteristic": "family history of PC",
                "p-value": "0.811"
            }
        }
    ],
    "PMC5762325_3": [
        {
            "subject": {
                "tissue_type": "tumor tissue sample",
                "e-cadherin_expression": "low",
                "styk1_expression": "low",
                "sample_count": "9",
                "correlation_coefficient": "-0.420",
                "p_value": "<0.001"
            }
        },
        {
            "subject": {
                "tissue_type": "tumor tissue sample",
                "e-cadherin_expression": "low",
                "styk1_expression": "high",
                "sample_count": "23",
                "correlation_coefficient": "-0.420",
                "p_value": "<0.001"
            }
        },
        {
            "subject": {
                "tissue_type": "tumor tissue sample",
                "e-cadherin_expression": "high",
                "styk1_expression": "low",
                "sample_count": "34"
            }
        },
        {
            "subject": {
                "tissue_type": "tumor tissue sample",
                "e-cadherin_expression": "high",
                "styk1_expression": "high",
                "sample_count": "14"
            }
        }
    ],
    "PMC3798558_3": [
        {
            "subject": {
                "gene": "XRCC1",
                "haplotype": "CG",
                "haplotype_number": "1",
                "snp1": "C",
                "snp2": "G",
                "overall_frequency": "0.439",
                "case_frequency": "0.433",
                "control_frequency": "0.442",
                "adjusted_or": "1.00",
                "reference": "ref.",
                "cases": "185",
                "controls": "1465"
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "haplotype": "CA",
                "haplotype_number": "2",
                "snp1": "C",
                "snp2": "A",
                "overall_frequency": "0.240",
                "case_frequency": "0.274",
                "control_frequency": "0.239",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[adjusted_or, p_value]",
            "outcomes": "[1.32 (1.01-1.71), 0.042]"
        },
        {
            "subject": {
                "gene": "XRCC1",
                "haplotype": "TG",
                "haplotype_number": "3",
                "snp1": "T",
                "snp2": "G",
                "overall_frequency": "0.319",
                "case_frequency": "0.292",
                "control_frequency": "0.318",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[adjusted_or, p_value]",
            "outcomes": "[1.05 (0.81-1.36), 0.691]"
        },
        {
            "subject": {
                "gene": "XRCC1",
                "haplotype": "TA",
                "haplotype_number": "4",
                "snp1": "T",
                "snp2": "A",
                "overall_frequency": "0.002",
                "case_frequency": "<0.001",
                "control_frequency": "0.002",
                "cases": "185",
                "controls": "1465",
                "adjusted_or": "N.E.",
                "p_value": "N.E."
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "snp1": "rs1799782",
                "snp2": "rs25487",
                "r_squared": "0.15"
            }
        },
        {
            "subject": {
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC"
            }
        }
    ],
    "PMC4423458_3": [
        {
            "subject": {
                "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "molecular_weight": "56 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[138.8]"
        },
        {
            "subject": {
                "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "molecular_weight": "56 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[52.1]"
        },
        {
            "subject": {
                "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "molecular_weight": "56 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[2.2, 0.01481]"
        },
        {
            "subject": {
                "protein": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "molecular_weight": "67 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[37.3]"
        },
        {
            "subject": {
                "protein": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "molecular_weight": "67 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[11.5]"
        },
        {
            "subject": {
                "protein": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "molecular_weight": "67 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[2.3, 0.04311]"
        },
        {
            "subject": {
                "protein": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "molecular_weight": "69 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[986.0]"
        },
        {
            "subject": {
                "protein": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "molecular_weight": "69 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[332.8]"
        },
        {
            "subject": {
                "protein": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "molecular_weight": "69 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[2.4, 0.00006]"
        },
        {
            "subject": {
                "protein": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "molecular_weight": "53 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[51.9]"
        },
        {
            "subject": {
                "protein": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "molecular_weight": "53 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[19.2]"
        },
        {
            "subject": {
                "protein": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "molecular_weight": "53 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[2.4, 0.03919]"
        },
        {
            "subject": {
                "protein": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "molecular_weight": "48 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[21.3]"
        },
        {
            "subject": {
                "protein": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "molecular_weight": "48 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[5.5]"
        },
        {
            "subject": {
                "protein": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "molecular_weight": "48 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[3.8, 0.01109]"
        },
        {
            "subject": {
                "protein": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "molecular_weight": "163 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[127.9]"
        },
        {
            "subject": {
                "protein": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "molecular_weight": "163 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[29.3]"
        },
        {
            "subject": {
                "protein": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "molecular_weight": "163 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[3.9, 0.00618]"
        },
        {
            "subject": {
                "protein": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "molecular_weight": "45 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[83.8]"
        },
        {
            "subject": {
                "protein": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "molecular_weight": "45 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[18.0]"
        },
        {
            "subject": {
                "protein": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "molecular_weight": "45 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[4.2, 0.00024]"
        },
        {
            "subject": {
                "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "molecular_weight": "52 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[89.3]"
        },
        {
            "subject": {
                "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "molecular_weight": "52 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[17.3]"
        },
        {
            "subject": {
                "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "molecular_weight": "52 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[4.3, 0.00133]"
        },
        {
            "subject": {
                "protein": "Complement C3 precursor",
                "accession": "115298678",
                "molecular_weight": "187 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[174.7]"
        },
        {
            "subject": {
                "protein": "Complement C3 precursor",
                "accession": "115298678",
                "molecular_weight": "187 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[35.6]"
        },
        {
            "subject": {
                "protein": "Complement C3 precursor",
                "accession": "115298678",
                "molecular_weight": "187 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[4.3, 0.00612]"
        },
        {
            "subject": {
                "protein": "Myeloperoxidase precursor",
                "accession": "4557759",
                "molecular_weight": "84 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[70.2]"
        },
        {
            "subject": {
                "protein": "Myeloperoxidase precursor",
                "accession": "4557759",
                "molecular_weight": "84 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[11.0]"
        },
        {
            "subject": {
                "protein": "Myeloperoxidase precursor",
                "accession": "4557759",
                "molecular_weight": "84 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[5.3, 0.02501]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "molecular_weight": "31 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[29.8]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "molecular_weight": "31 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[5.9]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "molecular_weight": "31 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[5.7, 0.02170]"
        },
        {
            "subject": {
                "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "molecular_weight": "95 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[63.3]"
        },
        {
            "subject": {
                "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "molecular_weight": "95 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[9.3]"
        },
        {
            "subject": {
                "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "molecular_weight": "95 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[6.4, 0.00031]"
        },
        {
            "subject": {
                "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "molecular_weight": "39 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[7.3]"
        },
        {
            "subject": {
                "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "molecular_weight": "39 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[1.1]"
        },
        {
            "subject": {
                "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "molecular_weight": "39 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[6.5, 0.00173]"
        },
        {
            "subject": {
                "protein": "Ceruloplasmin precursor",
                "accession": "4557485",
                "molecular_weight": "122 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[47.3]"
        },
        {
            "subject": {
                "protein": "Ceruloplasmin precursor",
                "accession": "4557485",
                "molecular_weight": "122 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[5.6]"
        },
        {
            "subject": {
                "protein": "Ceruloplasmin precursor",
                "accession": "4557485",
                "molecular_weight": "122 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[7.5, 0.00114]"
        },
        {
            "subject": {
                "protein": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "molecular_weight": "193 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[32.1]"
        },
        {
            "subject": {
                "protein": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "molecular_weight": "193 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[4.5]"
        },
        {
            "subject": {
                "protein": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "molecular_weight": "193 kDa"
            },
            "measures": "[normalized_spectral_abundance_factor_ratio, p_value]",
            "outcomes": "[7.7, 0.01791]"
        },
        {
            "subject": {
                "protein": "Alpha-1B-glycoprotein precursor",
                "accession": "21071030",
                "molecular_weight": "54 kDa",
                "group": "cancer"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[10.9]"
        },
        {
            "subject": {
                "protein": "Alpha-1B-glycoprotein precursor",
                "accession": "21071030",
                "molecular_weight": "54 kDa",
                "group": "control"
            },
            "measures": "[average_spectral_count]",
            "outcomes": "[1.2]"
        }
    ],
    "PMC5589562_2": [
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "1",
                "miRNA_probe_ID": "hsa-miR-145-5p",
                "accession_number": "MIMAT0000437"
            },
            "measures": "[ratio]",
            "outcomes": "[8980.05]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "2",
                "miRNA_probe_ID": "hsa-miR-199a-5p",
                "accession_number": "MIMAT0000231"
            },
            "measures": "[ratio]",
            "outcomes": "[1563.68]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "3",
                "miRNA_probe_ID": "hsa-miR-199b-5p",
                "accession_number": "MIMAT0000263"
            },
            "measures": "[ratio]",
            "outcomes": "[296.31]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "4",
                "miRNA_probe_ID": "hsa-miR-136-5p",
                "accession_number": "MIMAT0000448"
            },
            "measures": "[ratio]",
            "outcomes": "[228.24]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "5",
                "miRNA_probe_ID": "hsa-miR-137",
                "accession_number": "MIMAT0000429"
            },
            "measures": "[ratio]",
            "outcomes": "[227.70]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "6",
                "miRNA_probe_ID": "hsa-miR-139-5p",
                "accession_number": "MIMAT0000250"
            },
            "measures": "[ratio]",
            "outcomes": "[216.83]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "7",
                "miRNA_probe_ID": "hsa-miR-127-3p",
                "accession_number": "MIMAT0000446"
            },
            "measures": "[ratio]",
            "outcomes": "[159.72]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "8",
                "miRNA_probe_ID": "hsa-miR-337-5p",
                "accession_number": "MIMAT0004695"
            },
            "measures": "[ratio]",
            "outcomes": "[148.57]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "9",
                "miRNA_probe_ID": "hsa-miR-139-3p",
                "accession_number": "MIMAT0004552"
            },
            "measures": "[ratio]",
            "outcomes": "[146.36]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "10",
                "miRNA_probe_ID": "hsa-miR-487b",
                "accession_number": "MIMAT0003180"
            },
            "measures": "[ratio]",
            "outcomes": "[118.72]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "11",
                "miRNA_probe_ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                "accession_number": "MIMAT0000232"
            },
            "measures": "[ratio]",
            "outcomes": "[107.49]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "12",
                "miRNA_probe_ID": "hsa-miR-1233",
                "accession_number": "MIMAT0005588"
            },
            "measures": "[ratio]",
            "outcomes": "[66.04]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "13",
                "miRNA_probe_ID": "hsa-miR-379-5p",
                "accession_number": "MIMAT0000733"
            },
            "measures": "[ratio]",
            "outcomes": "[62.89]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "14",
                "miRNA_probe_ID": "hsa-miR-660-5p",
                "accession_number": "MIMAT0003338"
            },
            "measures": "[ratio]",
            "outcomes": "[62.50]"
        },
        {
            "subject": {
                "cell_type": "TAS cells",
                "expression_level": "highly expressed",
                "rank": "15",
                "miRNA_probe_ID": "hsa-miR-335-5p",
                "accession_number": "MIMAT0000765"
            },
            "measures": "[ratio]",
            "outcomes": "[60.53]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "1",
                "miRNA_probe_ID": "hsa-miR-205-5p",
                "accession_number": "MIMAT0000266"
            },
            "measures": "[ratio]",
            "outcomes": "[23077.19]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "2",
                "miRNA_probe_ID": "hsa-miR-200c-3p",
                "accession_number": "MIMAT0000617"
            },
            "measures": "[ratio]",
            "outcomes": "[5968.64]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "3",
                "miRNA_probe_ID": "hsa-miR-200b-3p",
                "accession_number": "MIMAT0000318"
            },
            "measures": "[ratio]",
            "outcomes": "[467.15]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "4",
                "miRNA_probe_ID": "hsa-miR-429",
                "accession_number": "MIMAT0001536"
            },
            "measures": "[ratio]",
            "outcomes": "[171.07]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "5",
                "miRNA_probe_ID": "hsa-miR-196b-5p",
                "accession_number": "MIMAT0001080"
            },
            "measures": "[ratio]",
            "outcomes": "[116.42]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "6",
                "miRNA_probe_ID": "hsa-miR-582-5p",
                "accession_number": "MIMAT0003247"
            },
            "measures": "[ratio]",
            "outcomes": "[99.53]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "7",
                "miRNA_probe_ID": "hsa-miR-135b-5p",
                "accession_number": "MIMAT0000758"
            },
            "measures": "[ratio]",
            "outcomes": "[87.82]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "8",
                "miRNA_probe_ID": "hsa-miR-182-5p",
                "accession_number": "MIMAT0000259"
            },
            "measures": "[ratio]",
            "outcomes": "[55.81]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "9",
                "miRNA_probe_ID": "hsa-miR-96-5p",
                "accession_number": "MIMAT0000095"
            },
            "measures": "[ratio]",
            "outcomes": "[53.82]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "10",
                "miRNA_probe_ID": "hsa-miR-200a-3p",
                "accession_number": "MIMAT0000682"
            },
            "measures": "[ratio]",
            "outcomes": "[44.88]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "11",
                "miRNA_probe_ID": "hsa-miR-4284",
                "accession_number": "MIMAT0016915"
            },
            "measures": "[ratio]",
            "outcomes": "[41.90]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "12",
                "miRNA_probe_ID": "hsa-miR-345-5p",
                "accession_number": "MIMAT0000772"
            },
            "measures": "[ratio]",
            "outcomes": "[27.99]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "13",
                "miRNA_probe_ID": "hsa-miR-378g",
                "accession_number": "MIMAT0018937"
            },
            "measures": "[ratio]",
            "outcomes": "[25.01]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "14",
                "miRNA_probe_ID": "hsa-miR-203",
                "accession_number": "MIMAT0000264"
            },
            "measures": "[ratio]",
            "outcomes": "[22.43]"
        },
        {
            "subject": {
                "cell_type": "PC cells",
                "expression_level": "highly expressed",
                "rank": "15",
                "miRNA_probe_ID": "hsa-miR-141-3p",
                "accession_number": "MIMAT0000432"
            },
            "measures": "[ratio]",
            "outcomes": "[21.69]"
        }
    ],
    "PMC4190529_6": [
        {
            "subject": {
                "treatment": "gemcitabine",
                "control": "5-fluorouracil",
                "phase": "3",
                "median_survival_therapy": "5.7",
                "median_survival_control": "4.2",
                "one_year_survival_therapy": "18%",
                "one_year_survival_control": "2%",
                "side_effects": "more favorable than 5-fluorouracil",
                "fda_approval": "1996"
            },
            "measures": "[median_survival, one_year_survival]",
            "outcomes": "[5.7, 18%]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "control": "gemcitabine",
                "phase": "3",
                "median_survival_therapy": "6.4",
                "median_survival_control": "6",
                "one_year_survival_therapy": "24%",
                "one_year_survival_control": "19%",
                "side_effects": "less favorable than gemcitabine",
                "fda_approval": "2005"
            },
            "measures": "[median_survival, one_year_survival]",
            "outcomes": "[6.4, 24%]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "control": "gemcitabine",
                "phase": "3",
                "median_survival_therapy": "8.5",
                "median_survival_control": "6.7",
                "one_year_survival_therapy": "35%",
                "one_year_survival_control": "22%",
                "side_effects": "less favorable than gemcitabine",
                "fda_approval": "2013"
            },
            "measures": "[median_survival, one_year_survival]",
            "outcomes": "[8.5, 35%]"
        },
        {
            "subject": {
                "treatment": "FOLFIRINOX",
                "control": "gemcitabine",
                "phase": "2/3",
                "median_survival_therapy": "11.1",
                "median_survival_control": "6.8",
                "one_year_survival_therapy": "48.4",
                "one_year_survival_control": "20.6",
                "side_effects": "less favorable than gemcitabine",
                "fda_approval": "n/a",
                "treatment_details": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
            },
            "measures": "[median_survival, one_year_survival]",
            "outcomes": "[11.1, 48.4]"
        },
        {
            "subject": {
                "treatment": "cell encapsulation + ifosfamide",
                "control": "5-fluorouracil",
                "phase": "2",
                "median_survival_therapy": "10",
                "median_survival_control": "5",
                "one_year_survival_therapy": "36%",
                "one_year_survival_control": "18%",
                "side_effects": "more favorable than 5-fluorouracil or gemcitabine",
                "fda_approval": "n/a",
                "toxicity": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2",
                "median_survival_higher_dose": "9.5 months"
            },
            "measures": "[median_survival, one_year_survival]",
            "outcomes": "[10, 36%]"
        }
    ],
    "PMC5675623_3": [
        {
            "subject": {
                "variable": "ECOG performance status",
                "contrast": "> 0 vs. 0"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.47 (0.90, 2.41), 0.12]"
        },
        {
            "subject": {
                "variable": "liver metastases",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.72 (1.01, 2.91), 0.045]"
        },
        {
            "subject": {
                "variable": "No. of metastatic sites",
                "contrast": ">2 vs. <= 2"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.33 (0.9, 2.25), 0.28]"
        },
        {
            "subject": {
                "variable": "prior radiation therapy",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.58 (0.95, 2.61), 0.077]"
        },
        {
            "subject": {
                "variable": "prior FOLFIRINOX",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.73 (1.01, 2.98), 0.046]"
        },
        {
            "subject": {
                "variable": "prior gemcitabine plus nab-paclitaxel treatment",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.08 (0.58, 2.01), 0.80]"
        },
        {
            "subject": {
                "analysis type": "multivariate Cox proportional hazards regression",
                "outcome measure": "overall survival",
                "treatment phase": "first phase I"
            }
        }
    ],
    "PMC4742219_3": [
        {
            "subject": {
                "variable": "age",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00 (0.98, 1.02), 0.874]"
        },
        {
            "subject": {
                "variable": "gender",
                "comparison": "female vs. male",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.89 (0.60, 1.31), 0.544]"
        },
        {
            "subject": {
                "variable": "tumor size",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.13 (0.97, 1.33), 0.127]"
        },
        {
            "subject": {
                "variable": "tumor grade",
                "comparison": "grade II vs. I",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00 (0.69, 1.45), 0.991]"
        },
        {
            "subject": {
                "variable": "tumor grade",
                "comparison": "grade III vs. I",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.93 (0.27, 3.17), 0.906]"
        },
        {
            "subject": {
                "variable": "lymph nodes",
                "comparison": "yes vs. no",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.39 (0.81, 2.38), 0.229]"
        },
        {
            "subject": {
                "variable": "margin",
                "comparison": "positive vs. negative",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.54 (1.06, 2.25), 0.025]"
        },
        {
            "subject": {
                "variable": "vascular invasion",
                "comparison": "yes vs. no",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.99 (0.69, 1.42), 0.967]"
        },
        {
            "subject": {
                "variable": "perineural invasion",
                "comparison": "yes vs. no",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[2.19 (0.87, 5.49), 0.097]"
        },
        {
            "subject": {
                "variable": "time from surgery to first recurrence",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00 (0.98, 1.02), 0.883]"
        },
        {
            "subject": {
                "variable": "recurrence pattern",
                "comparison": "lung + other vs. lung",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.25 (0.63, 2.48), 0.516]"
        },
        {
            "subject": {
                "variable": "recurrence pattern",
                "comparison": "liver + other vs. lung",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.91 (1.10, 3.31), 0.022]"
        },
        {
            "subject": {
                "variable": "recurrence pattern",
                "comparison": "peritoneal vs. lung",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[6.32 (3.12, 12.79), < .001]"
        },
        {
            "subject": {
                "variable": "recurrence pattern",
                "comparison": "local vs. lung",
                "analysis_type": "multivariable",
                "outcome": "time from recurrence to death"
            },
            "measures": "[HR, P value]",
            "outcomes": "[2.09 (1.10, 4.00), 0.025]"
        }
    ],
    "PMC4941379_3": [
        {
            "subject": {
                "chronic_atrophic_gastritis": "None",
                "h_pylori_infection": "IgG\u2212/CagA\u2212",
                "sample_size": "4555",
                "cases": "5"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[10.42, Ref, Ref]"
        },
        {
            "subject": {
                "chronic_atrophic_gastritis": "None",
                "h_pylori_infection": "IgG+/CagA\u2212",
                "sample_size": "1984",
                "cases": "2"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[9.54, Ref, 0.79 (0.15\u20134.08)]"
        },
        {
            "subject": {
                "chronic_atrophic_gastritis": "None",
                "h_pylori_infection": "IgG+/CagA+",
                "sample_size": "2295",
                "cases": "14"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[58.13, Ref, 5.05 (1.81\u201314.09)]"
        },
        {
            "subject": {
                "chronic_atrophic_gastritis": "Present",
                "h_pylori_infection": "IgG\u2212/CagA\u2212",
                "sample_size": "205",
                "cases": "0"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[0, 3.45 (1.38\u20138.64), Not estimable]"
        },
        {
            "subject": {
                "chronic_atrophic_gastritis": "Present",
                "h_pylori_infection": "IgG+/CagA\u2212",
                "sample_size": "143",
                "cases": "1"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[64.61, 3.45 (1.38\u20138.64), 5.50 (0.63\u201347.57)]"
        },
        {
            "subject": {
                "chronic_atrophic_gastritis": "Present",
                "h_pylori_infection": "IgG+/CagA+",
                "sample_size": "315",
                "cases": "5"
            },
            "measures": "[crude_incidence_rate, hr1, hr2]",
            "outcomes": "[151.20, 3.45 (1.38\u20138.64), 12.51 (3.57\u201343.22)]"
        }
    ],
    "PMC3987090_4": [
        {
            "subject": {
                "NLR threshold": "\u22641",
                "n": "14",
                "percentage": "5.6%",
                "median OS": "12.8 months",
                "median OS 95% CI lower": "9.4 months",
                "median OS 95% CI upper": "16.2 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">1",
                "n": "238",
                "percentage": "94.4%",
                "median OS": "11.7 months",
                "median OS 95% CI lower": "10.4 months",
                "median OS 95% CI upper": "13.0 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.68]"
        },
        {
            "subject": {
                "NLR threshold": "\u22641",
                "analysis type": "univariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[0.86, 3.29]"
        },
        {
            "subject": {
                "NLR threshold": "\u22641",
                "analysis type": "univariate"
            },
            "measures": "[p-value]",
            "outcomes": "[0.13]"
        },
        {
            "subject": {
                "NLR threshold": "\u22641",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">1",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.37]"
        },
        {
            "subject": {
                "NLR threshold": "\u22641",
                "analysis type": "multivariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[0.69, 2.71]"
        },
        {
            "subject": {
                "NLR threshold": "\u22641",
                "analysis type": "multivariate"
            },
            "measures": "[p-value]",
            "outcomes": "[0.37]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "n": "83",
                "percentage": "32.9%",
                "median OS": "14.8 months",
                "median OS 95% CI lower": "11.5 months",
                "median OS 95% CI upper": "18.2 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">2",
                "n": "169",
                "percentage": "67.1%",
                "median OS": "10.7 months",
                "median OS 95% CI lower": "9.3 months",
                "median OS 95% CI upper": "12.1 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.52]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "analysis type": "univariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.13, 2.05]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "analysis type": "univariate"
            },
            "measures": "[p-value]",
            "outcomes": "[0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">2",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.21]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "analysis type": "multivariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[0.88, 1.66]"
        },
        {
            "subject": {
                "NLR threshold": "\u22642",
                "analysis type": "multivariate"
            },
            "measures": "[p-value]",
            "outcomes": "[0.24]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "n": "158",
                "percentage": "62.7%",
                "median OS": "13.4 months",
                "median OS 95% CI lower": "11.1 months",
                "median OS 95% CI upper": "15.7 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">3",
                "n": "94",
                "percentage": "37.3%",
                "median OS": "8.6 months",
                "median OS 95% CI lower": "6.2 months",
                "median OS 95% CI upper": "11.0 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.68]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "analysis type": "univariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.26, 2.23]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "analysis type": "univariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">3",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.57]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "analysis type": "multivariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.18, 2.11]"
        },
        {
            "subject": {
                "NLR threshold": "\u22643",
                "analysis type": "multivariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "n": "194",
                "percentage": "77.0%",
                "median OS": "13.3 months",
                "median OS 95% CI lower": "11.4 months",
                "median OS 95% CI upper": "15.2 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">4",
                "n": "58",
                "percentage": "23.0%",
                "median OS": "7.3 months",
                "median OS 95% CI lower": "5.6 months",
                "median OS 95% CI upper": "9.0 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[2.00]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "analysis type": "univariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.44, 2.78]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "analysis type": "univariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">4",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.91]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "analysis type": "multivariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.36, 2.67]"
        },
        {
            "subject": {
                "NLR threshold": "\u22644",
                "analysis type": "multivariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "n": "212",
                "percentage": "84.1%",
                "median OS": "12.8 months",
                "median OS 95% CI lower": "10.7 months",
                "median OS 95% CI upper": "14.9 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">5",
                "n": "40",
                "percentage": "15.9%",
                "median OS": "6.0 months",
                "median OS 95% CI lower": "2.8 months",
                "median OS 95% CI upper": "9.2 months",
                "analysis type": "univariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[2.17]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "analysis type": "univariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.50, 3.15]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "analysis type": "univariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "NLR threshold": ">5",
                "analysis type": "multivariate"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[2.16]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "analysis type": "multivariate"
            },
            "measures": "[95% CI lower, 95% CI upper]",
            "outcomes": "[1.49, 3.15]"
        },
        {
            "subject": {
                "NLR threshold": "\u22645",
                "analysis type": "multivariate"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.01]"
        }
    ],
    "PMC3987090_5": [
        {
            "subject": {
                "study": "An X et al.",
                "year": "2010",
                "n": "89",
                "number_of_patients_with_nlr_gt_5": "16",
                "percentage_of_patients_with_nlr_gt_5": "17.9"
            },
            "measures": "[overall_survival_nlr_gt_5, overall_survival_nlr_lte_5]",
            "outcomes": [
                "[2.4, 7.7]",
                "[hazard_ratio, p_value]",
                "[4.49, 0.013]"
            ]
        },
        {
            "subject": {
                "study": "Wang DS et al.",
                "year": "2012",
                "n": "86",
                "number_of_patients_with_nlr_gt_5": "12",
                "percentage_of_patients_with_nlr_gt_5": "13.9"
            },
            "measures": "[overall_survival_nlr_gt_5, overall_survival_nlr_lte_5]",
            "outcomes": "[5.8, 10.2]"
        },
        {
            "subject": {
                "study": "Stotz M et al",
                "year": "2013",
                "n": "261",
                "number_of_patients_with_nlr_gt_5": "79",
                "percentage_of_patients_with_nlr_gt_5": "30.3",
                "chemotherapy_patients": "179",
                "no_chemotherapy_patients": "82"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[2.53, <0.01]"
        },
        {
            "subject": {
                "study": "Our study",
                "year": "2013",
                "n": "253",
                "number_of_patients_with_nlr_gt_5": "40",
                "percentage_of_patients_with_nlr_gt_5": "15.8"
            },
            "measures": "[overall_survival_nlr_gt_5, overall_survival_nlr_lte_5]",
            "outcomes": [
                "[6.0, 12.8]",
                "[hazard_ratio, p_value]",
                "[1.95, <0.01]"
            ]
        }
    ],
    "PMC3544459_4": [
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "no",
                "median_survival_time": "33.2 \u00b1 1.8",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "0.049"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, 0.050]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "no",
                "median_survival_time": "33.2 \u00b1 1.8",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "0.049"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, 0.036]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "yes",
                "median_survival_time": "24.6 \u00b1 2.5",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "0.049"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.27 (1.00\u20131.60), 0.050]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "yes",
                "median_survival_time": "24.6 \u00b1 2.5",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "0.049"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.29 (1.02\u20131.64), 0.036]"
        },
        {
            "subject": {
                "condition": "perineural_invasion",
                "perineural_invasion_status": "no",
                "median_survival_time": "51.7 \u00b1 31.1",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "perineural_invasion",
                "perineural_invasion_status": "no",
                "median_survival_time": "51.7 \u00b1 31.1",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, 0.019]"
        },
        {
            "subject": {
                "condition": "perineural_invasion",
                "perineural_invasion_status": "yes",
                "median_survival_time": "29.4 \u00b1 1.64",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[2.01 (1.38\u20132.93), <0.001]"
        },
        {
            "subject": {
                "condition": "perineural_invasion",
                "perineural_invasion_status": "yes",
                "median_survival_time": "29.4 \u00b1 1.64",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.60 (1.08\u20132.36), 0.019]"
        },
        {
            "subject": {
                "condition": "margin_status",
                "margin_status": "negative",
                "median_survival_time": "33.6 \u00b1 1.7",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "margin_status",
                "margin_status": "negative",
                "median_survival_time": "33.6 \u00b1 1.7",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, 0.003]"
        },
        {
            "subject": {
                "condition": "margin_status",
                "margin_status": "positive",
                "median_survival_time": "24.8 \u00b1 2.6",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.62 (1.27\u20132.08), <0.001]"
        },
        {
            "subject": {
                "condition": "margin_status",
                "margin_status": "positive",
                "median_survival_time": "24.8 \u00b1 2.6",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.47 (1.14\u20131.90), 0.003]"
        },
        {
            "subject": {
                "condition": "node_status",
                "node_status": "negative",
                "median_survival_time": "38.6 \u00b1 5.3",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "node_status",
                "node_status": "negative",
                "median_survival_time": "38.6 \u00b1 5.3",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, 0.002]"
        },
        {
            "subject": {
                "condition": "node_status",
                "node_status": "positive",
                "median_survival_time": "27.5 \u00b1 1.3",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.70 (1.35\u20132.15), <0.001]"
        },
        {
            "subject": {
                "condition": "node_status",
                "node_status": "positive",
                "median_survival_time": "27.5 \u00b1 1.3",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.45 (1.14\u20131.83), 0.002]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "well\u2013moderate",
                "median_survival_time": "35.9 \u00b1 2.68",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "well\u2013moderate",
                "median_survival_time": "35.9 \u00b1 2.68",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "poor",
                "median_survival_time": "26.0 \u00b1 1.77",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "poor",
                "median_survival_time": "26.0 \u00b1 1.77",
                "median_survival_time_unit": "months",
                "p_value_log_rank": "<0.001"
            },
            "measures": "[hazard_ratio, p_value]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001]"
        }
    ],
    "PMC3497287_3": [
        {
            "subject": {
                "inherited_syndrome": "Lynch Syndrome",
                "mutated_gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2"
            }
        },
        {
            "subject": {
                "inherited_syndrome": "Peutz-Jeghers Syndrome",
                "mutated_gene": "STK11/LKB1"
            }
        },
        {
            "subject": {
                "inherited_syndrome": "Hereditary Breast Cancer",
                "mutated_gene": "BRCA1/BRCA2"
            }
        },
        {
            "subject": {
                "inherited_syndrome": "Familial Atypical Multiple Mole Melanoma",
                "mutated_gene": "CDKN2A mutation"
            }
        }
    ],
    "PMC4728116_3": [
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "family history of pancreatic cancer": "no",
                "cases_n": "312",
                "cases_percentage": "96.6",
                "controls_n": "320",
                "controls_percentage": "99.1"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "family history of pancreatic cancer": "yes",
                "cases_n": "11",
                "cases_percentage": "3.4",
                "controls_n": "3",
                "controls_percentage": "0.9"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[3.67, 4.04, 1.23]"
        },
        {
            "subject": {
                "characteristic": "bmi",
                "bmi": "<24.0",
                "cases_n": "197",
                "cases_percentage": "61.0",
                "controls_n": "230",
                "controls_percentage": "71.2"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "bmi",
                "bmi": "\u226524.0",
                "cases_n": "126",
                "cases_percentage": "39.0",
                "controls_n": "93",
                "controls_percentage": "28.8"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.67, 1.78, 1.77]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "diabetes": "no",
                "cases_n": "174",
                "cases_percentage": "78.0",
                "controls_n": "255",
                "controls_percentage": "90.7"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "diabetes": "yes",
                "cases_n": "49",
                "cases_percentage": "22.0",
                "controls_n": "26",
                "controls_percentage": "9.3"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[2.69, 2.60, 2.96]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "cholecystitis": "no",
                "cases_n": "272",
                "cases_percentage": "94.1",
                "controls_n": "195",
                "controls_percentage": "96.7"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "cholecystitis": "yes",
                "cases_n": "17",
                "cases_percentage": "5.9",
                "controls_n": "10",
                "controls_percentage": "3.3"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.89, 1.91, 1.35]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "gallstone": "no",
                "cases_n": "274",
                "cases_percentage": "95.1",
                "controls_n": "300",
                "controls_percentage": "98.4"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "gallstone": "yes",
                "cases_n": "14",
                "cases_percentage": "4.9",
                "controls_n": "5",
                "controls_percentage": "1.6"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[2.80, 2.58, 2.68]"
        }
    ],
    "PMC4741511_2": [
        {
            "subject": {
                "population_subgroup": "Sorafenib group",
                "ldh_level": "LDH \u2264 UNR",
                "patients_number": "31",
                "patients_percentage": "44"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[7.6, 12.7]"
        },
        {
            "subject": {
                "population_subgroup": "Sorafenib group",
                "ldh_level": "LDH > UNR",
                "patients_number": "6",
                "patients_percentage": "8"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.8, 5.9]"
        },
        {
            "subject": {
                "population_subgroup": "No Sorafenib group",
                "ldh_level": "LDH \u2264 UNR",
                "patients_number": "27",
                "patients_percentage": "38"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[3.3, 8.6]"
        },
        {
            "subject": {
                "population_subgroup": "No Sorafenib group",
                "ldh_level": "LDH > UNR",
                "patients_number": "7",
                "patients_percentage": "10"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.2, 5.2]"
        },
        {
            "subject": {
                "study_name": "MAPS",
                "study_phase": "II",
                "treatment_comparison": "chemotherapy plus sorafenib vs chemotherapy alone"
            },
            "measures": "[PFS p-value, OS p-value]",
            "outcomes": "[0.05, 0.0012]"
        }
    ],
    "PMC5522086_3": [
        {
            "subject": {
                "upstream_regulator": "TP53",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.353, 3.34e-32]"
        },
        {
            "subject": {
                "upstream_regulator": "NUPR1",
                "regulation": "inhibition",
                "log_ratio": "-2.52"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.977, 4.62e-13]"
        },
        {
            "subject": {
                "upstream_regulator": "NKX2-3",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.455, 5.88e-12]"
        },
        {
            "subject": {
                "upstream_regulator": "HNF1A",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.359, 8.82e-12]"
        },
        {
            "subject": {
                "upstream_regulator": "CDKN2A",
                "regulation": "inhibition",
                "log_ratio": "1.737"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.219, 1.34e-11]"
        },
        {
            "subject": {
                "upstream_regulator": "estrogen receptor",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.299, 9.57e-10]"
        },
        {
            "subject": {
                "upstream_regulator": "RB1",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-4.286, 3.74e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "TCF3",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.116, 4.32e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "TRIM24",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.714, 6.26e-07]"
        },
        {
            "subject": {
                "upstream_regulator": "BCL6",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.313, 1.60e-06]"
        },
        {
            "subject": {
                "upstream_regulator": "NR5A2",
                "regulation": "inhibition",
                "log_ratio": "-2.876"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.7, 7.26e-06]"
        },
        {
            "subject": {
                "upstream_regulator": "SATB1",
                "regulation": "inhibition",
                "log_ratio": "-0.814"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.003, 1.09e-05]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF4",
                "regulation": "inhibition",
                "log_ratio": "2.115"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.41, 4.24e-05]"
        },
        {
            "subject": {
                "upstream_regulator": "RBL1",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-3.124, 1.72e-04]"
        },
        {
            "subject": {
                "upstream_regulator": "SPDEF",
                "regulation": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[-2.887, 2.39e-04]"
        },
        {
            "subject": {
                "upstream_regulator": "STAT3",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.924, 5.78e-19]"
        },
        {
            "subject": {
                "upstream_regulator": "CTNNB1",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.359, 1.99e-15]"
        },
        {
            "subject": {
                "upstream_regulator": "SP1",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.06, 4.79e-13]"
        },
        {
            "subject": {
                "upstream_regulator": "CEBPB",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.866, 2.62e-12]"
        },
        {
            "subject": {
                "upstream_regulator": "NFkB (complex)",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[6.314, 1.43e-11]"
        },
        {
            "subject": {
                "upstream_regulator": "TBX2",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[4.99, 1.62e-11]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF1",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.759, 2.76e-11]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF7",
                "regulation": "activation",
                "log_ratio": "1.504"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[5.591, 2.88e-10]"
        },
        {
            "subject": {
                "upstream_regulator": "FOXM1",
                "regulation": "activation",
                "log_ratio": "2.152"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[4.395, 5.12e-10]"
        },
        {
            "subject": {
                "upstream_regulator": "STAT1",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[4.576, 2.05e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "ETS1",
                "regulation": "activation",
                "log_ratio": "0.863"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.575, 5.06e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "JUN",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.045, 5.57e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "FOXO1",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.242, 9.35e-08]"
        },
        {
            "subject": {
                "upstream_regulator": "E2F3",
                "regulation": "activation",
                "log_ratio": "1.137"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.394, 1.16e-06]"
        },
        {
            "subject": {
                "upstream_regulator": "MBD2",
                "regulation": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.549, 5.41e-06]"
        }
    ],
    "PMC3428781_1": [
        {
            "subject": {
                "PSC state": "Quiescent PSCs",
                "Vitamin A lipid droplets": "Present",
                "\u03b1 Smooth muscle actin": "Absent",
                "Proliferation": "Limited",
                "Migration": "Limited",
                "Extracellular matrix production": "Limited",
                "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)": "Complement of MMPs and TIMPs to maintain normal ECM turnover",
                "Production of cytokines": "Limited",
                "Capacity for phagocytosis": "Absent",
                "Proteomic analyses": "Basal protein expression"
            }
        },
        {
            "subject": {
                "PSC state": "Activated PSCs",
                "Vitamin A lipid droplets": "Absent",
                "\u03b1 Smooth muscle actin": "Present",
                "Proliferation": "Increased",
                "Migration": "Increased",
                "Extracellular matrix production": "Increased",
                "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)": "Change in types of MMPs and TIMPs to facilitate ECM deposition",
                "Production of cytokines": "Increased",
                "Cytokines produced": "PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15",
                "Capacity for phagocytosis": "Present",
                "Proteomic analyses": "Differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion"
            }
        }
    ],
    "PMC4941331_3": [
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "cytoplasmic",
                "protein_2_location": "nuclear",
                "protein_1_expression": "low",
                "protein_2_expression": "low",
                "sample_size": "34"
            }
        },
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "cytoplasmic",
                "protein_2_location": "nuclear",
                "protein_1_expression": "low",
                "protein_2_expression": "high",
                "sample_size": "22"
            }
        },
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "cytoplasmic",
                "protein_2_location": "nuclear",
                "protein_1_expression": "high",
                "protein_2_expression": "low",
                "sample_size": "4"
            }
        },
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "cytoplasmic",
                "protein_2_location": "nuclear",
                "protein_1_expression": "high",
                "protein_2_expression": "high",
                "sample_size": "24"
            }
        },
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "cytoplasmic",
                "protein_2_location": "nuclear"
            },
            "measures": "[correlation_coefficient, p_value]",
            "outcomes": "[0.440, < 0.001]"
        },
        {
            "subject": {
                "protein_1": "CDH1",
                "protein_2": "HDAC3",
                "protein_1_location": "membrane",
                "protein_2_location": "nuclear"
            },
            "measures": "[correlation_coefficient, p_value]",
            "outcomes": "[-0.348, 0.001]"
        }
    ],
    "PMC6062623_3": [
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "right",
                "density": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.76, 0.002]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "right",
                "density": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.15, 0.008]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "right",
                "density": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.25, 0.006]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "right",
                "density": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.08, 0.009]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "left",
                "density": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-1.04, 0.32]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "left",
                "density": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-2.58, 0.022]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "left",
                "density": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.36, 0.005]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph_metric": "local efficiency",
                "hemisphere": "left",
                "density": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.04, 0.01]"
        }
    ],
    "PMC5464866_2": [
        {
            "subject": {
                "tissue_type": "cancerous tissues",
                "sample_size": "88",
                "marker": "FXR"
            },
            "measures": "[positive, negative]",
            "outcomes": "[54 (61.4%), 34 (38.6%)]"
        },
        {
            "subject": {
                "tissue_type": "adjacent tissues",
                "sample_size": "88",
                "marker": "FXR"
            },
            "measures": "[positive, negative]",
            "outcomes": "[27 (30.7%), 61 (69.3%)]"
        },
        {
            "subject": {
                "comparison": "cancerous tissues vs adjacent tissues",
                "marker": "FXR",
                "statistical_test": "not specified"
            },
            "measures": "[p-value]",
            "outcomes": "[<0.05]"
        }
    ],
    "PMC5687650_6": [
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "gender",
                "risk_factor_categories": "women or men"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.770 (0.528-1.124), 0.175]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "age",
                "risk_factor_categories": ">65 years or \u226465years"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.773 (0.537-1.110), 0.163]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "PLR",
                "risk_factor_categories": "high or low"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.922 (0.641-1.325), 0.660]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "NLR",
                "risk_factor_categories": "high or low"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.007 (0.701-1.448), 0.969]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "post/pre-chemotherapy PLR ratio",
                "risk_factor_categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.272 (0.881-1.837), 0.199]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "post/pre-chemotherapy NLR ratio",
                "risk_factor_categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "risk_factor": "post/pre-chemotherapy NLR ratio",
                "risk_factor_categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        }
    ],
    "PMC5464866_1": [
        {
            "subject": {
                "FXR expression": "Low",
                "Year": "0",
                "Number at risk": "87",
                "Percentage at risk": "49.7%"
            }
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Year": "2",
                "Number at risk": "16",
                "Percentage at risk": "9.1%"
            }
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Year": "4",
                "Number at risk": "6",
                "Percentage at risk": "3.4%"
            }
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Year": "6",
                "Number at risk": "1",
                "Percentage at risk": "0.6%"
            }
        },
        {
            "subject": {
                "FXR expression": "High",
                "Year": "0",
                "Number at risk": "88",
                "Percentage at risk": "50.3%"
            }
        },
        {
            "subject": {
                "FXR expression": "High",
                "Year": "2",
                "Number at risk": "9",
                "Percentage at risk": "5.1%"
            }
        },
        {
            "subject": {
                "FXR expression": "High",
                "Year": "4",
                "Number at risk": "3",
                "Percentage at risk": "1.7%"
            }
        },
        {
            "subject": {
                "FXR expression": "High",
                "Year": "6",
                "Number at risk": "0",
                "Percentage at risk": "0.0%"
            }
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Median survival time (year)": "1.83"
            }
        },
        {
            "subject": {
                "FXR expression": "High",
                "Median survival time (year)": "1.78"
            }
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Survival rate": "Three year survival rate"
            },
            "measures": "[Survival rate, 95% CI lower bound, 95% CI upper bound]",
            "outcomes": "[0.4288, 0.3020, 0.6089]"
        },
        {
            "subject": {
                "FXR expression": "Low",
                "Survival rate": "Five year survival rate"
            },
            "measures": "[Survival rate]",
            "outcomes": "[0.3127]"
        },
        {
            "subject": {
                "FXR expression": "High",
                "Survival rate": "Three year survival rate"
            },
            "measures": "[Survival rate, 95% CI lower bound, 95% CI upper bound]",
            "outcomes": "[0.3036, 0.1646, 0.5600]"
        },
        {
            "subject": {
                "FXR expression": "High",
                "Survival rate": "Five year survival rate"
            },
            "measures": "[Survival rate]",
            "outcomes": "[0.2277]"
        }
    ],
    "PMC5641200_3": [
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "red blood cells count decreased"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[5 (83), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "leukopenia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[3 (50), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "neutropenia"
            },
            "measures": "[grade 1]",
            "outcomes": "[4 (67)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "AST increase"
            },
            "measures": "[grade 1, grade 3]",
            "outcomes": "[3 (50), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "ALT increase"
            },
            "measures": "[grade 1, grade 2, grade 3]",
            "outcomes": "[4 (67), 1 (17), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "GGT increase"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (17), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "hypocalcemia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (17), 2 (33)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "hyponatremia"
            },
            "measures": "[grade 1, grade 3]",
            "outcomes": "[1 (17), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "nausea"
            },
            "measures": "[grade 1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "vomiting"
            },
            "measures": "[grade 1]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "diarrhea"
            },
            "measures": "[grade 2, grade 3]",
            "outcomes": "[2 (33), 2 (33)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "abdominal pain"
            },
            "measures": "[grade 1]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "oral mucositis"
            },
            "measures": "[grade 1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "dyspepsia"
            },
            "measures": "[grade 1]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "dysgeusia"
            },
            "measures": "[grade 1]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "anorexia"
            },
            "measures": "[grade 1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "alopecia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (17), 4 (67)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "fatigue"
            },
            "measures": "[grade 1, grade 3]",
            "outcomes": "[3 (50), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "peripheral sensory neuropathy"
            },
            "measures": "[grade 1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "arthralgia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[2 (33), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "myalgia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (17), 1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "1",
                "dose": "<100 mg",
                "n": "6",
                "adverse_event": "LVEF decrease"
            },
            "measures": "[grade 2]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "red blood cells count decreased"
            },
            "measures": "[grade 1]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "leukopenia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[2 (50), 1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "neutropenia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "AST increase"
            },
            "measures": "[grade 1]",
            "outcomes": "[4 (100)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "ALT increase"
            },
            "measures": "[grade 1]",
            "outcomes": "[3 (75)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "hypocalcemia"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "hyponatremia"
            },
            "measures": "[grade 3]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "nausea"
            },
            "measures": "[grade 2, grade 3]",
            "outcomes": "[2 (50), 1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "vomiting"
            },
            "measures": "[grade 3]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "diarrhea"
            },
            "measures": "[grade 1, grade 2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "abdominal pain"
            },
            "measures": "[grade 3]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "dysgeusia"
            },
            "measures": "[grade 2]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "anorexia"
            },
            "measures": "[grade 2]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "alopecia"
            },
            "measures": "[grade 1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "fatigue"
            },
            "measures": "[grade 2]",
            "outcomes": "[3 (75)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "pneumonitis"
            },
            "measures": "[grade 3]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "peripheral sensory neuropathy"
            },
            "measures": "[grade 1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "arthralgia"
            },
            "measures": "[grade 1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "drug": "dasatinib",
                "dose_level": "2",
                "dose": "100 mg",
                "n": "4",
                "adverse_event": "pericardial effusion"
            },
            "measures": "[grade 2]",
            "outcomes": "[1 (25)]"
        }
    ],
    "PMC5716794_2": [
        {
            "subject": {
                "ROI size": "55 mm^2",
                "Optimal cutoff values": "1.70 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.687",
                "SE": "0.079",
                "CI": "0.575\u22120.785",
                "Sensitivities": "89.1",
                "Sensitivities CI": "78.8\u221295.5",
                "Specificities": "50.0",
                "Specificities CI": "26.0\u221274.0",
                "PPV": "86.4%",
                "NPV": "56.3%",
                "ACC": "80.5%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
        },
        {
            "subject": {
                "ROI size": "82 mm^2",
                "Optimal cutoff values": "1.72 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.694",
                "SE": "0.077",
                "CI": "0.582\u22120.791",
                "Sensitivities": "90.6",
                "Sensitivities CI": "80.7\u221296.5",
                "Specificities": "50.0",
                "Specificities CI": "26.0\u221274.0",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "ACC": "81.7%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "ROI size": "99 mm^2",
                "Optimal cutoff values": "1.73 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.707",
                "SE": "0.074",
                "CI": "0.596\u22120.802",
                "Sensitivities": "90.6",
                "Sensitivities CI": "80.7\u221296.5",
                "Specificities": "50.0",
                "Specificities CI": "26.0\u221274.0",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "ACC": "81.7%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "ROI size": "134 mm^2",
                "Optimal cutoff values": "1.74 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.731",
                "SE": "0.070",
                "CI": "0.622\u22120.823",
                "Sensitivities": "90.6",
                "Sensitivities CI": "80.7\u221296.5",
                "Specificities": "50.0",
                "Specificities CI": "26.0\u221274.0",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "ACC": "81.7%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "ROI size": "152 mm^2",
                "Optimal cutoff values": "1.70 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.751",
                "SE": "0.067",
                "CI": "0.643\u22120.840",
                "Sensitivities": "89.1",
                "Sensitivities CI": "78.8\u221295.5",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "87.7%",
                "NPV": "58.9%",
                "ACC": "81.7%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "ROI size": "161 mm^2",
                "Optimal cutoff values": "1.70 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.756",
                "SE": "0.065",
                "CI": "0.649\u22120.844",
                "Sensitivities": "89.1",
                "Sensitivities CI": "78.8\u221295.5",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "87.7%",
                "NPV": "58.9%",
                "ACC": "81.7%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "ROI size": "189 mm^2",
                "Optimal cutoff values": "1.75 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.770",
                "SE": "0.062",
                "CI": "0.664\u22120.856",
                "Sensitivities": "90.6",
                "Sensitivities CI": "80.7\u221296.5",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "87.9%",
                "NPV": "62.5%",
                "ACC": "82.9%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
        },
        {
            "subject": {
                "ROI size": "214 mm^2",
                "Optimal cutoff values": "1.79 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.788",
                "SE": "0.059",
                "CI": "0.684\u22120.871",
                "Sensitivities": "92.2",
                "Sensitivities CI": "82.7\u221297.4",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "88.1%",
                "NPV": "66.7%",
                "ACC": "84.2%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
        },
        {
            "subject": {
                "ROI size": "223 mm^2",
                "Optimal cutoff values": "1.79 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.793",
                "SE": "0.058",
                "CI": "0.689\u22120.874",
                "Sensitivities": "93.8",
                "Sensitivities CI": "84.8\u221298.3",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "88.3%",
                "NPV": "71.6%",
                "ACC": "85.4%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
        },
        {
            "subject": {
                "ROI size": "245 mm^2",
                "Optimal cutoff values": "1.79 \u00d7 10^\u22123 mm^2/s",
                "AUC": "0.800",
                "SE": "0.056",
                "CI": "0.697\u22120.881",
                "Sensitivities": "95.3",
                "Sensitivities CI": "86.9\u221299.0",
                "Specificities": "55.6",
                "Specificities CI": "30.8\u221278.5",
                "PPV": "88.4%",
                "NPV": "76.9%",
                "ACC": "86.6%"
            },
            "measures": "[AUC, Sensitivities, Specificities, PPV, NPV, ACC]",
            "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
        },
        {
            "subject": {
                "Imaging technique": "Diffusion-weighted imaging",
                "Measurement": "Apparent diffusion coefficient",
                "Comparison": "Pancreatic adenocarcinoma vs healthy pancreas"
            }
        }
    ],
    "PMC3757392_2": [
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell_line": "Capan-1",
                "icc": "++",
                "confocal": "++"
            },
            "measures": "[flow, do]",
            "outcomes": "[40, 170]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell_line": "Cfpac-1",
                "icc": "+++",
                "confocal": "+++"
            },
            "measures": "[flow, do]",
            "outcomes": "[500, 140]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell_line": "Panc-1",
                "icc": "+++",
                "confocal": "+++"
            },
            "measures": "[flow, do]",
            "outcomes": "[80, 160]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell_line": "Capan-1",
                "icc": "++",
                "confocal": "++"
            },
            "measures": "[flow, do]",
            "outcomes": "[88, 190]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell_line": "Cfpac-1",
                "icc": "+++",
                "confocal": "+++"
            },
            "measures": "[flow, do]",
            "outcomes": "[92, 130]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell_line": "Panc-1",
                "icc": "+++",
                "confocal": "+++"
            },
            "measures": "[flow, do]",
            "outcomes": "[91, 170]"
        },
        {
            "subject": {
                "vector": "2200-2500",
                "cell_line": "all cells"
            },
            "measures": "[do]",
            "outcomes": "[2200-2500]"
        }
    ]
}